• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

大鼠模型中血管化复合异体移植排斥反应过程的免疫和炎症图谱

Immunological and inflammatory mapping of vascularized composite allograft rejection processes in a rat model.

作者信息

Friedman Or, Carmel Narin, Sela Meirav, Abu Jabal Ameen, Inbal Amir, Ben Hamou Moshe, Krelin Yakov, Gur Eyal, Shani Nir

机构信息

The Plastic Reconstructive Surgery Department, Tel Aviv Sourasky Medical Center, Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel.

出版信息

PLoS One. 2017 Jul 26;12(7):e0181507. doi: 10.1371/journal.pone.0181507. eCollection 2017.

DOI:10.1371/journal.pone.0181507
PMID:28746417
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5528841/
Abstract

BACKGROUND

Hand and face vascularized composite allotransplantation (VCA) is an evolving and challenging field with great opportunities. During VCA, massive surgical damage is inflicted on both donor and recipient tissues, which may contribute to the high VCA rejection rates. To segregate between the damage-induced and rejection phase of post-VCA responses, we compared responses occurring up to 5 days following syngeneic versus allogeneic vascularized groin flap transplantations, culminating in transplant acceptance or rejection, respectively.

METHODS

The immune response elicited upon transplantation of a syngeneic versus allogeneic vascularized groin flap was compared at Post-operative days 2 or 5 by histology, immunohistochemistry and by broad-scope gene and protein analyses using quantitative real-time PCR and Multiplex respectively.

RESULTS

Immune cell infiltration began at the donor-recipient interface and paralleled expression of a large group of wound healing-associated genes in both allografts and syngrafts. By day 5 post-transplantation, cell infiltration spread over the entire allograft but remained confined to the wound site in the syngraft. This shift correlated with upregulation of IL-18, INFg, CXCL9, 10 and 11, CCL2, CCL5, CX3CL1 and IL-10 in the allograft only, suggesting their role in the induction of the anti-alloantigen adaptive immune response.

CONCLUSIONS

High resemblance between the cues governing VCA and solid organ rejection was observed. Despite this high resemblance we describe also, for the first time, a damage induced inflammatory component in VCA rejection as immune cell infiltration into the graft initiated at the surgical damage site spreading to the entire allograft only at late stage rejection. We speculate that the highly inflammatory setting created by the unique surgical damage during VCA may enhance acute allograft rejection.

摘要

背景

手部和面部血管化复合组织异体移植(VCA)是一个不断发展且具有挑战性但机遇巨大的领域。在VCA过程中,供体和受体组织都会受到大规模手术损伤,这可能是导致VCA排斥率高的原因之一。为了区分VCA术后损伤诱导阶段和排斥阶段的反应,我们比较了同基因与异基因血管化腹股沟皮瓣移植后5天内的反应,最终分别导致移植被接受或排斥。

方法

通过组织学、免疫组织化学以及分别使用定量实时PCR和多重分析进行的广泛基因和蛋白质分析,比较同基因与异基因血管化腹股沟皮瓣移植术后第2天或第5天引发的免疫反应。

结果

免疫细胞浸润始于供体 - 受体界面,并且在同种异体移植和同基因移植中,一大组与伤口愈合相关基因的表达与之平行。移植后第5天,细胞浸润扩散至整个同种异体移植,但在同基因移植中仍局限于伤口部位。这种转变仅与同种异体移植中IL - 18、INFg、CXCL9、10和11、CCL2、CCL5、CX3CL1及IL - 10的上调相关,表明它们在诱导抗同种异体抗原适应性免疫反应中的作用。

结论

观察到VCA和实体器官排斥的调控线索之间具有高度相似性。尽管有这种高度相似性,但我们也首次描述了VCA排斥中损伤诱导的炎症成分,即免疫细胞从手术损伤部位开始浸润到移植物中,仅在排斥后期扩散至整个同种异体移植。我们推测VCA过程中独特的手术损伤所造成的高度炎症环境可能会增强急性同种异体移植排斥反应。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8421/5528841/525ca5fe72d2/pone.0181507.g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8421/5528841/766417548a65/pone.0181507.g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8421/5528841/19311b128a32/pone.0181507.g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8421/5528841/f7a9e557cdd4/pone.0181507.g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8421/5528841/a86140408cb7/pone.0181507.g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8421/5528841/824dbcab59d7/pone.0181507.g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8421/5528841/93b72996cb99/pone.0181507.g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8421/5528841/fb73e2e32bd9/pone.0181507.g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8421/5528841/525ca5fe72d2/pone.0181507.g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8421/5528841/766417548a65/pone.0181507.g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8421/5528841/19311b128a32/pone.0181507.g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8421/5528841/f7a9e557cdd4/pone.0181507.g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8421/5528841/a86140408cb7/pone.0181507.g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8421/5528841/824dbcab59d7/pone.0181507.g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8421/5528841/93b72996cb99/pone.0181507.g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8421/5528841/fb73e2e32bd9/pone.0181507.g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8421/5528841/525ca5fe72d2/pone.0181507.g008.jpg

相似文献

1
Immunological and inflammatory mapping of vascularized composite allograft rejection processes in a rat model.大鼠模型中血管化复合异体移植排斥反应过程的免疫和炎症图谱
PLoS One. 2017 Jul 26;12(7):e0181507. doi: 10.1371/journal.pone.0181507. eCollection 2017.
2
A novel rat full-thickness hemi-abdominal wall/hindlimb osteomyocutaneous combined flap: influence of allograft mass and vascularized bone marrow content on vascularized composite allograft survival.一种新型大鼠全层半腹壁/后肢骨肌皮联合皮瓣:同种异体移植物质量和带血管骨髓含量对血管化复合组织异体移植存活的影响。
Transpl Int. 2014 Sep;27(9):977-86. doi: 10.1111/tri.12364. Epub 2014 Jul 29.
3
The combination of mitomycin-induced blood cells with a temporary treatment of ciclosporin A prolongs allograft survival in vascularized composite allotransplantation.丝裂霉素诱导的血细胞与环孢素A的短期治疗相结合可延长血管化复合异体移植中同种异体移植物的存活时间。
Langenbecks Arch Surg. 2018 Feb;403(1):83-92. doi: 10.1007/s00423-017-1616-3. Epub 2017 Aug 19.
4
Desensitization and Prevention of Antibody-Mediated Rejection in Vascularized Composite Allotransplantation by Syngeneic Hematopoietic Stem Cell Transplantation.通过同基因造血干细胞移植实现血管化复合组织同种异体移植中的脱敏和预防抗体介导的排斥反应。
Transplantation. 2018 Apr;102(4):593-600. doi: 10.1097/TP.0000000000002070.
5
Vascularized composite allograft-specific characteristics of immune responses.血管化复合异体移植免疫反应的特异性特征。
Transpl Int. 2016 Jun;29(6):672-81. doi: 10.1111/tri.12765. Epub 2016 Mar 21.
6
The Influence of Timing and Frequency of Adipose-Derived Mesenchymal Stem Cell Therapy on Immunomodulation Outcomes After Vascularized Composite Allotransplantation.脂肪间充质干细胞治疗的时机和频率对血管化复合组织异体移植后免疫调节结果的影响
Transplantation. 2017 Jan;101(1):e1-e11. doi: 10.1097/TP.0000000000001498.
7
Donor Recipient Chimeric Cells Induce Chimerism and Extend Survival of Vascularized Composite Allografts.供者受者嵌合细胞诱导嵌合体并延长血管化复合同种异体移植物的存活。
Arch Immunol Ther Exp (Warsz). 2021 May 10;69(1):13. doi: 10.1007/s00005-021-00614-9.
8
The contribution of the donor vascularised hand and face allograft in transplant rejection: An immunological perspective.供体血管化手部和面部同种异体移植在移植排斥反应中的作用:免疫学视角。
Transpl Immunol. 2024 Jun;84:102035. doi: 10.1016/j.trim.2024.102035. Epub 2024 Mar 21.
9
Effect of the vascularized bone components on the survival of vascularized composite allografts.带血管骨成分对带血管异体复合组织移植存活的影响。
J Surg Res. 2018 Apr;224:132-138. doi: 10.1016/j.jss.2017.03.050. Epub 2017 Apr 6.
10
Vascularized composite allotransplantation: current standards and novel approaches to prevent acute rejection and chronic allograft deterioration.血管化复合组织异体移植:预防急性排斥反应和慢性移植物退变的现行标准及新方法
Transpl Int. 2016 Jun;29(6):655-62. doi: 10.1111/tri.12652. Epub 2015 Sep 14.

引用本文的文献

1
C-reactive protein induced T cell activation is an indirect monocyte-dependent mechanism involving the CD80/CD28 pathway.C反应蛋白诱导的T细胞活化是一种间接的单核细胞依赖机制,涉及CD80/CD28途径。
Front Immunol. 2025 Jul 18;16:1622865. doi: 10.3389/fimmu.2025.1622865. eCollection 2025.
2
Unraveling the Roles of Macrophages in Vascularized Composite Allotransplantation.解析巨噬细胞在血管化复合组织移植中的作用
Biomedicines. 2025 Jun 10;13(6):1425. doi: 10.3390/biomedicines13061425.
3
Perioperative effects of dexmedetomidine on renal function in allogeneic kidney transplant patients: a meta-analysis.

本文引用的文献

1
The decade of face transplant outcomes.面部移植成果的十年。
J Mater Sci Mater Med. 2017 May;28(5):64. doi: 10.1007/s10856-017-5873-z. Epub 2017 Mar 16.
2
Immunopathology of rejection: do the rules of solid organ apply to vascularized composite allotransplantation?排斥反应的免疫病理学:实体器官移植的规则是否适用于血管化复合组织异体移植?
Curr Opin Organ Transplant. 2015 Dec;20(6):596-601. doi: 10.1097/MOT.0000000000000242.
3
Delayed graft function and the risk of acute rejection in the modern era of kidney transplantation.移植肾功能延迟恢复与现代肾移植时代的急性排斥反应风险
右美托咪定对同种异体肾移植患者围手术期肾功能的影响:一项荟萃分析。
Int Urol Nephrol. 2025 May 19. doi: 10.1007/s11255-025-04576-1.
4
Donor adipose-derived stromal cells are vasoprotectant but unable to revert acute rejection in rodent vascularized composite allotransplants.供体脂肪来源的基质细胞具有血管保护作用,但无法逆转啮齿动物血管化复合异体移植中的急性排斥反应。
Front Immunol. 2025 Apr 28;16:1581599. doi: 10.3389/fimmu.2025.1581599. eCollection 2025.
5
New Paradigms in Rejection Monitoring: Lymphocyte Subsets as Noninvasive Graft Markers in Vascularized Composite Allotransplantation.排斥反应监测的新范式:淋巴细胞亚群作为血管化复合组织异体移植中的非侵入性移植物标志物
Plast Reconstr Surg Glob Open. 2025 Mar 6;13(3):e6598. doi: 10.1097/GOX.0000000000006598. eCollection 2025 Mar.
6
Autologous porcine VRAM flap model for VCA research.用于血管化复合组织移植(VCA)研究的自体猪腹直肌肌皮瓣模型
Front Transplant. 2024 Dec 6;3:1504959. doi: 10.3389/frtra.2024.1504959. eCollection 2024.
7
Molecular Signature Associated With Acute Rejection in Vascularized Composite Allotransplantation.与血管化复合组织异体移植急性排斥相关的分子特征
Transplant Direct. 2024 Sep 19;10(10):e1714. doi: 10.1097/TXD.0000000000001714. eCollection 2024 Oct.
8
Immunogenicity and tolerance induction in vascularized composite allotransplantation.血管化复合组织同种异体移植中的免疫原性与免疫耐受诱导
Front Transplant. 2024 Feb 13;3:1350546. doi: 10.3389/frtra.2024.1350546. eCollection 2024.
9
Design of a Multiparametric Perfusion Bioreactor System for Evaluating Sub-Normothermic Preservation of Rat Abdominal Wall Vascularized Composite Allografts.用于评估大鼠腹壁带血管化复合异体移植物亚常温保存的多参数灌注生物反应器系统的设计
Bioengineering (Basel). 2024 Mar 25;11(4):307. doi: 10.3390/bioengineering11040307.
10
Methods of ex vivo analysis of tissue status in vascularized composite allografts.血管化复合异体移植物组织状态的离体分析方法。
J Transl Med. 2023 Sep 8;21(1):609. doi: 10.1186/s12967-023-04379-x.
Kidney Int. 2015 Oct;88(4):851-8. doi: 10.1038/ki.2015.190. Epub 2015 Jun 24.
4
Hand and upper extremity transplantation: an update of outcomes in the worldwide experience.手部及上肢移植:全球经验中的结果更新
Plast Reconstr Surg. 2015 Feb;135(2):351e-360e. doi: 10.1097/PRS.0000000000000892.
5
Acute rejection in vascularized composite allotransplantation.血管化复合组织异体移植中的急性排斥反应。
Curr Opin Organ Transplant. 2014 Dec;19(6):531-44. doi: 10.1097/MOT.0000000000000140.
6
Insights from computational modeling in inflammation and acute rejection in limb transplantation.肢体移植中炎症与急性排斥反应的计算模型见解
PLoS One. 2014 Jun 13;9(6):e99926. doi: 10.1371/journal.pone.0099926. eCollection 2014.
7
Facial transplantation: the first 9 years.面部移植:9 年历程。
Lancet. 2014 Dec 13;384(9960):2153-63. doi: 10.1016/S0140-6736(13)62632-X. Epub 2014 Apr 27.
8
Inflammatory triggers of acute rejection of organ allografts.器官同种异体移植急性排斥反应的炎症触发因素。
Immunol Rev. 2014 Mar;258(1):132-44. doi: 10.1111/imr.12146.
9
Facial and hand allotransplantation.面部和手部同种异体移植。
Cold Spring Harb Perspect Med. 2014 Mar 1;4(3):a015651. doi: 10.1101/cshperspect.a015651.
10
Urine proteomics in kidney transplantation.尿液蛋白质组学在肾移植中的应用。
Transplant Rev (Orlando). 2014 Jan;28(1):15-20. doi: 10.1016/j.trre.2013.10.004. Epub 2013 Oct 24.